If you wish to contact vidalistaact20 by e-mail, please register or log in.

Vidalista CT 20, like other Tadalafil formulations, has been studied for its potential to treat pulmonary arterial hypertension (PAH), a condition characterized by high blood pressure in the lungs. Tadalafil works by relaxing the blood vessels in the lungs, which helps to lower the pressure. While the drug is already FDA-approved for PAH under the brand name Adcirca, ongoing research aims to fine-tune its efficacy in treating this condition and to explore whether lower doses of Vidalista CT 20 could be effective for managing PAH without causing significant side effects.